Delivery Order SPE2DB20D3104-SPE2DB23FV6E7

Award Date 4/18/23
Potential Completion Date 4/19/23
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,415.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a Delivery Order under an Indefinite Delivery Contract (IDC), covers the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of December 17, 2024 and uses a Firm Fixed Price pricing type. The award was not designated under any set-aside...
This is a $5,253.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for the supply of 4565632370 - CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,898.14 firm fixed-price delivery order contract is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of January 9, 2024 and does not...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,648.58 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on March 1, 2024. This award does not utilize a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
The Defense Logistics Agency (DLA) awarded a $4,785.12 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Corlanor 5 mg tablets, a cardiovascular medication, with a period of performance through October 2024. This delivery order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running...
This contract award, valued at $3,061.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of pharmaceutical product CORLANOR 5 MG TABLET 60S, with a completion date of April 8, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,001.74 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563817620 CORLANOR 5 MG TABLET 60S. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical...
This is a $3,105.82 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through February 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.26 firm fixed-price delivery order is for the supply of CORLANOR 7.5 MG TABLET 60S, a medication used to treat heart failure. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,198.75, is for the delivery of 4565166920 CORLANOR 5 MG TABLET 60S, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV6E7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,504.66 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4560633735 - CORLANOR 5 MG TABLET 60S. This contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition. AmerisourceBergen is also an approved vendor for the Department of Justice Federal Bureau of Investigation, with a separate $750,000 IDC through May 2024 covering similar medical commodities.

Generated 2/27/25, 10:24 AM